Myth: Tocolysis for prevention of preterm birth has a major role in modern obstetrics

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 5, 2011, Pages 242-246

  Kenyon, A P ^a   Peebles, D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Neonatal outcome; Preterm labour; Tocolytic; Uterine contraction

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; ENDOTOXIN; ERYTHROMYCIN; HYDROXYPROGESTERONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUNG SURFACTANT; MAGNESIUM SULFATE; NITRIC OXIDE DONOR; PLACEBO; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA; UTERUS SPASMOLYTIC AGENT;

AMNION FLUID; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHORIOAMNIONITIS; COMPETITIVE INHIBITION; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DUCTUS ARTERIOSUS; DYSPNEA; FETUS DEATH; FETUS MEMBRANE; FLUSHING; FOLLOW UP; HEART PALPITATION; HUMAN; HYPOTENSION; INFLAMMATION; INJECTION SITE REACTION; INTRAUTERINE INFECTION; MOTHER; NAUSEA; NAUSEA AND VOMITING; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUROLOGIC DISEASE; NEUROPROTECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OBSTETRIC CARE; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SIDE EFFECT; SWEATING; TACHYCARDIA; THORAX PAIN; TOCOLYSIS; UTERINE CERVIX RIPENING; UTERUS CONTRACTION;

FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; OBSTETRICS; PREGNANCY; PREMATURE BIRTH; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 79960972047     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2011.04.008     Document Type: Review

References (44)

1. Royal College of Obstetricians and Gynaecologists Pre term labour: Proceedings of the fifth study group of the Royal College of Obstetricians and Gynaecologists 1977, RCOG, London.
2. Langhoff-Roos J., Kesmodel U., Jacobsson B., Rasmussen S., Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 2006, 332:937-939.
3. Iams J.D., Romero R., Culhane J.F., Goldenberg R.L. Preterm birth 2. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008, 371:164-175.
4. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126:443-456.
5. Conde-Agudelo A., Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 2009, 200:595-609.
6. Larroque B., Ancel P.Y., Marret S., et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008, 371:813-820.
7. Kenyon S., Pike K., Jones D.R., et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008, 372:1310-1318.
8. Kenyon S., Pike K., Jones D.R., et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008, 372:1319-1327.
9. Vrachnis N., Vitoratos N., Iliodromiti Z., Sifakis S., Deligeoroglou E., Creatsas G. Intrauterine inflammation and preterm delivery. Ann N Y Acad Sci 2010, 1205:118-122.
10. Lindstrom T.M., Bennett P.R. The role of nuclear factor kappa B in human labour. Reproduction 2005, 130:569-581.
11. Jones H.E., Harris K.A., Azizia M., et al. Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLoS One 2009, 4(12).
12. Goldenberg R.L., Hauth J.C., Andrews W.W. Mechanisms of disease - intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
13. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998, 179:194-202.
14. Wu Y.W., Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000, 284:1417-1424.
15. Leviton A., Paneth N., Reuss M.L., et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res 1999, 46:566-575.
16. Lau J., Magee F., Qiu Z.G., Hoube J., Von Dadelszen P., Lee S.K. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005, 193:708-713.
17. Yoon B.H., Romero R., Yang S.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174:1433-1440.
18. Yoon B.H., Jun J.K., Romero R., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta and tumor necrosis factor-alpha). Neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997, 177:19-26.
19. Royal College of Obstetricians and Gynaecologists Tocolytic drugs for women in preterm labour. Greentop Guideline 2010, RCOG, London.
20. Haas D.M., Imperiale T.F., Kirkpatrick P.R., Klein R.W., Zollinger T.W., Golichowski A.M. Tocolytic therapy - a meta-analysis and decision analysis. Obstet Gynecol 2009, 113:585-594.
21. Haas D.M., Golichowski A.M., Imperiale T.F., Kirkpatrick P.R., Zollinger T.W., Klein R.W. Tocolytic therapy: a meta-analysis and decision analysis reply. Obstet Gynecol 2009, 114:171.
22. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., Grp O.C. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 2001, 357:979-988.
23. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 2001, 357:989-994.
24. Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials 1972 to 1994. Am J Obstet Gynecol 1995, 173:322-335.
25. Royal College of Obstetricians and Gynaecologists Antenatal corticosteroids to prevent respiratory distress syndrome. Greentop Guideline 2004, RCOG, London.
26. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, (3). CD004454.
27. Berkman N.D., Thorp J.M., Lohr K.N., et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol 2003, 188:1648-1659.
28. Romero R., Sibai B.M., Sanchez-Ramos L., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000, 182:1173-1183.
29. Gyetvai K., Hannah M.E., Hodnett E.D., Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999, 94:869-877.
30. Papatsonis D., Flenady V., Cole S., Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005, (3). CD004452.
31. Fenton A.C., Ainsworth S.B., Sturgiss S.N. Population-based outcomes after acute antenatal transfer. Paediatr Perinat Epidemiol 2002, 16:278-285.
32. Doyle L.W., Crowther C.A., Middleton P., Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007, (3). CD004661.
33. Groom K.M., Shennan A.H., Jones B.A., Seed P., Bennett P.R. TOCOX - a randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. Int J Obstet Gynaecol 2005, 112:725-730.
34. Koren G., Florescu A., Costei A.M., Boskovic R., Moretti M.E. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 2006, 40:824-829.
35. Ostensen M.E., Skomsvoll J.F. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004, 5:571-580.
36. Fonseca E.B., Celik E., Parra M., et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007, 357:462-469.
37. da Fonseca E.B., Bittar R.E., Carvalho M.H.B., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003, 188:419-424.
38. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348:2379-2385.
39. O'Brien J.M., DeFranco E.A., Adair C.D., et al. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2009, 34:653-659.
40. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:687-696.
41. Norman J.E., Mackenzie F., Owen P., et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009, 373:2034-2040.
42. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: national clinical practice guidelines March 2010, Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel, AMSNGDPA, Adelaide, Available from. http://www.adelaide.edu.au/arch/.
43. Leeson S.C., Maresh M.J.A., Martindale E.A., et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynaecol 1996, 103:48-53.
44. Carvalho M., Bittar R.E., Brizot M., Maganha P., Borges E., Zugaib M. Cervical length at 11-14 weeks' and 22-24 weeks' gestation evaluated by transvaginal sonography, and gestational age at delivery. Ultrasound Obstet Gynecol 2003, 21:5.